SCHEMBL24675781

SCHEMBL24675781

CCCCCCCCOCCOCCOCCCC(=O)N1CCN(C)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GNAI3 P08754 9/20 0.58
▸ GNAI1 P63096 9/20 0.58
▸ GNAO1 P09471 8/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ THRB P10828 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRA P10827 1/20 0.43
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CES2 O00748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25819361 0.91 GNAI3 (0.48) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL23484812 0.86 GNAI3 (0.51) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL8972852 0.85 GNAI3 (0.71) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL31632756 0.85 GNAI3 (0.71) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL4548016 0.85 GNAI3 (0.71) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL3339374 0.85 GNAI3 (0.71) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL8972071 0.85 GNAI3 (0.71) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL8972364 0.85 GNAI3 (0.71) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL8972105 0.85 GNAI3 (0.71) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL8973186 0.85 GNAI3 (0.71) GNAI3GNAI1GNAO1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022159688-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2022-07-28 — — WO disclosed
Send feedback